These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 6206249)

  • 1. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
    Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
    AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
    Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP
    Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of maternal serum alpha fetoprotein screening on open neural tube defect births in north-east Scotland.
    Thom H; Campbell AG; Farr V; Fisher PM; Hall MH; Swapp GH; Gray ES
    Prenat Diagn; 1985; 5(1):15-9. PubMed ID: 2579374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening.
    Greene MF; Benacerraf BR
    Obstet Gynecol; 1991 Apr; 77(4):520-4. PubMed ID: 1706079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
    Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM
    J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.
    Layde PM; von Allmen SD; Oakley GP
    Am J Public Health; 1979 Jun; 69(6):566-73. PubMed ID: 87134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.
    Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A
    BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
    Doran TA; Valentine GH; Wong PY; Wielgosz G; Benzie RJ; Soltan HC; Jenner MR; Morland PA; Montgomery RJ; Allen LC
    CMAJ; 1987 Aug; 137(4):285-93. PubMed ID: 2440547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of a serum screening service for neural-tube defects: the South Wales experience.
    Roberts CJ; Hibbard BM; Elder GH; Evans KT; Laurence KM; Roberts A; Woodhead JS; Robertson IB; Hoole M
    Lancet; 1983 Jun; 1(8337):1315-8. PubMed ID: 6190057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
    Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC
    Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
    CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of abnormally high and low maternal serum alpha-fetoprotein levels between 14 and 25 weeks of gestation.
    Ko TM; Hsieh FJ; Wu CC; Chang CH; Hsieh RF; Liu IJ; Hsieh CY; Lee TY
    J Formos Med Assoc; 1990 Jun; 89(6):456-60. PubMed ID: 1700059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
    Candenas M; Villa R; Fernandez Collar R; Moina MJ; Pintado S; Garcia Saez F; Alvarez FV
    Acta Obstet Gynecol Scand; 1995 Apr; 74(4):266-9. PubMed ID: 7537429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.